Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials Editorial


Authors: Basch, E.; Leahy, A. B.
Title: Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials
Abstract: All MSK authors verified as per deleted WOS duplicate (CMB 2020-05-06)
Keywords: fatigue; diarrhea; note; disease association; coughing; dyspnea; fever; pruritus; rash; immunotherapy; immunomodulating agent; drug labeling; patient reported outcome measures; adverse drug reaction; national health organization; drug use; product development; programmed death 1 ligand 1; musculoskeletal pain; patient-reported outcome; quality of life assessment; humans; human; priority journal; disease assessment; b7-h1 antigen
Journal Title: Clinical Trials
Volume: 16
Issue: 3
ISSN: 1740-7745
Publisher: Sage Publications  
Date Published: 2019-06-01
Start Page: 327
End Page: 328
Language: English
DOI: 10.1177/1740774519836989
PUBMED: 30895807
PROVIDER: scopus
DOI/URL:
Notes: Note -- Export Date: 1 May 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ethan Martin Basch
    180 Basch